Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would think about new talks with insurers about the checklist prices of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies. Elevance lowers guidance https://label-the-figure-with-the19764.anchor-blog.com/10939110/considerations-to-know-about-healthcare-news